Coronary IVL TCT Data By the Numbers
Consistent Over Time
Longest-term analysis of coronary IVL, Disrupt CAD III, confirms consistency of the excellent safety and effectiveness outcomes at 30 days out to one year.
TCT Slides: Disrupt CAD III 1yr by Dr. Jonathan Hill
DOWNLOAD
Dr. Jonathan Hill Presents the CAD III 1yr Data
WATCH VIDEO
Q&A: Dr. Dean Kereiakes
Disrupt CAD III 1yr
Data at TCT21
Data at TCT21
Dr. Dean Kereiakes
Co-Principal Investigator of DISRUPT CAD III, the Coronary IVL U.S. IDE Study
Consistent Across Calcium Morphologies
Most rigorous OCT pooled analysis of any calcium modification therapy in over 250 patients showcases IVL’s ability to achieve excellent MSA and stent expansion consistently across different calcium morphologies.
TCT Slides: Disrupt CAD Pooled OCT Eccentric Analysis
IVL OCT Data Overview
TCT Slides: Disrupt CAD Pooled OCT Nodular Analysis
Q&A: Dr. Ziad Ali
Coronary IVL in Eccentric vs Concentric Lesions at TCT21
Dr. Ziad Ali
St. Francis Hospital and Heart Center
Roslyn, NY
Q&A: Akiko Maehara
Coronary IVL in Nodular Calcium at TCT21
Dr. Akiko Maehara
Columbia University Irving Medical Center
New York, NY
Consistent Outcomes Between Women & Men
Unlike previous findings with atherectomy1 , IVL showed consistent safety outcomes in men and women despite more frequent comorbidities and smaller vessel size in women.
TCT Slides: Disrupt CAD Pooled Gender Analysis
Q&A: Dr. Yasin Hussain
Coronary IVL outcomes in Men vs Women at TCT21
Dr. Yasin Hussain
Yale-New Haven Hospital,
New Haven, CT